Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
13,813,202
-
Share change
-
+833,163
-
Total reported value
-
$520,292,852
-
Put/Call ratio
-
46%
-
Price per share
-
$37.73
-
Number of holders
-
155
-
Value change
-
+$34,612,076
-
Number of buys
-
70
-
Number of sells
-
78
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q2 2020
As of 30 Jun 2020 Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) had 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,813,202 shares of stock of the company.
Largest 10 holders included BlackRock Inc., KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, AMERIPRISE FINANCIAL INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Avidity Partners Management LP, Boston Trust Walden Corp, and ACADIAN ASSET MANAGEMENT LLC.
This table shows 155 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.